Previous studies have indicated that ketone body-mediated contractile failure in rat hearts is due to inhibition of 2-oxoglutarate dehydrogenase, and it has been speculated that this inhibition is due to the sequestration of intramitochondrial CoA as acetoacetyl-CoA and acetyl-CoA. These studies were performed to determine whether oxidation of acetoacetate by isolated rat heart mitochondria results in a fall in intramitochondrial nonesterified CoA ICoASHI and whether increasing the available CoA improves contractile performance in hearts oxidizing acetoacetate. The oxidation of acetoacetate by isolated rat heart mitochondria resulted in depressed state 3 respiration as well as in a decrease in ICoASHI. Increasing the tissue content of CoASH in perfused hearts by providing the precursors for CoA relieved inhibition of 2-oxoglutarate dehydrogenase and improved the contractile performance of isolated working hearts. In contrast, the addition ofcarnitine increased the tissue content of CoASH but did not improve function. These findings suggest the presence of two different pools of CoASH. We conclude that ketone body-mediated inhibition of 2-oxoglutarate dehydrogenase is due to decreased intramitochondrial CoASH and that this inhibition of the citric acid cycle is a plausible mechanism for concomitant contractile failure. (J. Clin. Invest. 1992. 89:968-973.) Key words: acetoacetate *2-oxoglutarate dehydrogenase * citric acid cycle * rat heart Introduction Oxidation of ketone bodies as a sole substrate by the isolated working rat heart results in reversible contractile failure (1, 2), despite the ability ofmammalian hearts to utilize ketone bodies as fuel for respiration (3). We (1) and others (4, 5) have previously suggested that the failure results from inhibition of the citric acid cycle at the level of 2-oxoglutarate dehydrogenase through the sequestration of the required cofactor nonesterified CoA (CoASH)1 as the thioesters acetoacetyl-CoA and ace-
Introduction
Oxidation of ketone bodies as a sole substrate by the isolated working rat heart results in reversible contractile failure (1, 2) , despite the ability ofmammalian hearts to utilize ketone bodies as fuel for respiration (3) . We (1) and others (4, 5) have previously suggested that the failure results from inhibition of the citric acid cycle at the level of 2-oxoglutarate dehydrogenase through the sequestration of the required cofactor nonesterified CoA Receivedforpublication 25 June 1991 and in revisedform 4 October 1991. 1 . Abbreviation used in this paper: CoASH, nonesterified CoA. Because the above findings suggest that free CoASH may be rate limiting for the 2-oxoglutarate dehydrogenase reaction, it seemed logical to assume that increasing the supply ofCoASH may improve contractile function in hearts oxidizing acetoacetate. The tissue content of CoASH can be increased in one of two ways. First, the relative distribution of CoA between nonesterified CoASH and esterified CoA (e.g., acetyl-CoA, fatty acyl-CoA) can be altered by the provision ofL-carnitine, which has been shown to result in the transfer of acetyl units from acetyl-CoA and acetoacetyl-CoA to carnitine via the action of the enzyme carnitine acetyltransferase (4, 6) , thereby forming acetylcarnitine and acetoacetylcarnitine while increasing the tissue content ofCoASH. This is supported by the observations that the addition ofcarnitine to isolated rat heart mitochondria oxidizing acetoacetate resulted in an increase in state 3 respiration (4, 5) and that the incubation of isolated mitochondria with carnitine increases levels of intramitochondrial CoASH and decreases levels of acetyl-CoA (6). Because carnitine is readily transported across the sarcolemma (7), it may be possible to increase intracellular levels ofcarnitine in the intact heart in an attempt to "buffer" acetyl-CoA and acetoacetyl-CoA as the carnitine esters acetylcarnitine and acetoacetylcarnitine.
The second manner in which the tissue content of CoASH can be elevated relies on the increased synthesis of CoA by providing exogenous sources of the precursors of CoA, pantothenic acid and cysteine (8) . The provision of these precursors without any exogenous energy-providing substrate has been shown to result in a 50% increase in the tissue content of total CoA (9) . It has previously been demonstrated that the enrichment of the CoA pool decreases the oxidation of palmitate and increases the incorporation of palmitate into triacylglycerols (9) , but the effect of elevated levels ofCoA on ketone body metabolism is not known.
It was, therefore, the goal of this study to determine, first, whether the metabolism of ketone bodies results in a fall in intramitochondrial concentrations of CoASH and, second, whether measures aimed at increasing the myocardial content of CoASH are effective in improving flux through 2-oxoglutarate dehydrogenase and thereby improving contractile function in hearts oxidizing ketone bodies.
Methods
Heart perfusions. Rat hearts were perfused in the working rat heart perfusion apparatus previously described (10) Determination of intramitochondrial CoASH, NAD', and 2-oxoglutarate. Mitochondria were isolated from the hearts of adult, male Sprague-Dawley rats using the Nagarse method of Idell-Wenger et al. (13) . Mitochondria (8 mg mitochondrial protein) were incubated at 250C in sucrose (200 mM), 3-N-morpholino)propanesulfonic acid (MOPS; 10 mM), and potassium phosphate (10 mM, pH 7.4) containing ADP (320 nM), glucose (50 mM), hexokinase (40 U), dextran (60 mg/ml), and malate (5 mM). In addition to the above, either acetoacetate (5 mM) or pyruvate (5 mM) was added as a substrate. Glucose and hexokinase were added as a regenerating system for extramitochondrial ADP, and dextran was added to enhance sedimentation of mitochondria during centrifugation ( 14) . To determine extramitochondrial sucrose space and intramitochondrial volume, respectively, [U-'4C]-sucrose and 3H20 were added to the incubation media.
The mitochondrial suspensions were incubated for 5 min in a microcentrifuge tube (EppendorfInc., Fremont, CA) containing a layer of silicone oil overlying 500 ul of perchloric acid ( 16% wt/vol). After the 5-min incubation period, the tubes were immediately centrifuged for 30 s in a benchtop microcentrifuge, sedimenting the mitochondria through the silicone oil and into the perchloric acid. The incubation medium was then removed and acidified.
Both the acidified mitochondrial extracts and the incubation media were neutralized and assayed fluorimetrically for CoASH, NAD', and 2-oxoglutarate (15) . The intramitochondrial content ofeach ofthe metabolites was determined by correcting the metabolite content of the mitochondrial extracts for the metabolite content ofincubation media trapped in the extramitochondrial space (16) . Oxygen consumption was determined for mitochondria oxidizing either pyruvate (5 mM) or acetoacetate (5 mM) in media containing sucrose (250 mM), 3-Nmorpholino)propanesulfonic acid (MOPS; 10 mM), potassium phosphate (10 mM), malate (5 mM), and ADP (320 nM) by the method of Chance and Williams (17) . Mitochondrial protein content was determined by the Biuret reaction (18) after mitochondrial samples were solubilized by the addition of deoxycholate to a final concentration of 1%.
Tissue metabolite analysis. Fluorimetric determinations of CoASH, acetyl-CoA, 3-ketoacyl-CoA derivatives (which includes acetoacetyl-CoA), acetylcarnitine, 3-ketoacylcarnitine, 2-oxoglutarate, glutamate, and succinyl-CoA were performed on perchloric acid extracts of frozen tissue samples ( 15) . Because the enzyme used in the determination of acetoacetyl-CoA, fl-hydroxyacyl-CoA dehydrogenase, has very little chain length specificity, the results of this assay represent the total acid-soluble 3-ketoacyl-CoA pool. Total CoA was determined fluorimetrically on extracts from tissue samples hydrolyzed with ethanolic KOH (15) . The values for all tissue metabolites are expressed as micromoles per gram dry weight. All values are reported as the mean±SEM. (Table I) , the provision of greater amounts of CoASH should improve performance in hearts oxidizing ketone bodies. Fig. 1 represents the cardiac output and pressure-volume work after 60 min of perfusion for hearts perfused with either acetoacetate or acetoacetate plus carnitine (preload: 15 cm H20, afterload: 140 cm H20). As expected, there was a dramatic and rapid fall in both cardiac output and pressure-volume work for hearts using acetoacetate as the sole substrate. Although hearts oxidizing acetoacetate in the presence of carnitine had a greater initial cardiac output and pressure-volume work, the decline in both cardiac output and pressure-volume work was similar to that for hearts oxidizing acetoacetate alone. In addition, increasing the concentration of carnitine in the perfusate (from 0.5 to 5 mM) did not improve function (data not presented).
Results
Because the addition of carnitine to hearts oxidizing acetoacetate failed to improve contractile function, as would be predicted by the mitochondrial studies cited earlier (4, 5) , it was important to determine whether carnitine altered the distribution ofC2 and C4 units between their CoA and carnitine derivatives. Despite the decline in contractile function for hearts perfused with carnitine, there was a 24% increase in the tissue level of acetylcarnitine and an eightfold increase in the level of 3-ketoacylcarnitine (including acetoacetylcarnitine) in hearts perfused with acetoacetate plus carnitine compared with hearts perfused with acetoacetate alone (Table II ). In addition, there Tim(e, y) no change in either the coronary flow or heart rate for either group during the preperfusion period (data not presented). Carrdiac output and pressure-volume work for working rat diac output and pressure-volume work were similar for hearts )) oxidizing acetoacetate (5 mM) either alone (o) or with preperfused with CoA precursors and hearts preperfused with mM; .). *P < 0.05 compared with time zero for the no exogenous precursors during the first 10 min of perfusion Dup; tP < 0.05 compared with time zero for hearts oxi- (Fig. 2) . However, by 20 
Discussion
The above findings are consistent with the mechanism of sequestration ofCoASH first described by Hulsmann et al. (4, 5) and further advanced by Taegtmeyer (1) . In this mechanism, the activation of ketone bodies to acetoacetyl-CoA by 3- (2) . Limitation of CoASH has been implicated as a regulatory mechanism in several other pathways. In animal tissues, sequestration of CoASH has been suggested to result in inhibition of hepatic pyruvate carboxylase during the metabolism of sodium benzoate (23) . Further, the inhibition of fatty acid oxidation by the action of 5-(tetradecyloxy)-2-furoic acid is thought to be mediated by decreasing the available CoASH (24) . Sequestration of CoASH has even been implicated in the regulation of2-oxoglutarate dehydrogenase and pyruvate dehydrogenase activities in plant mitochondria (25) . Consistent with the findings of this study, it has been shown that partial protection against metabolic inhibition by erucic acid is afforded by elevated levels of CoA in brown adipose tissue (26, 27) . In a situation somewhat reversed from those mentioned above and our current findings, it has been suggested that the hepatotoxic effects of valproic acid or other organic acids that require CoA activation can be reversed by the addition ofparachlorobenzoic acid or para-nitrobenzoic acid, which compete with the toxic agents for CoA (28) . With the decrease in intramitochondrial [CoASH] confirmed, it was the second goal of these studies to determine whether it would be possible to enrich the mitochondrial pool of CoASH. Earlier investigators have shown that the addition of L-carnitine to mitochondrial suspensions results in the buffering of acyl-CoA derivatives (6) . That is, there is an extramitochondrial accumulation of acetylcarnitine with a fall in the intramitochondrial concentration of acetyl-CoA and an increase in the intramitochondrial concentration offree CoASH. This study indicates that carnitine, at high extracellular concentrations, can indeed change the overall cellular distribution of short chain acyl groups between their CoA and carnitine derivatives, but this redistribution of acyl groups does not improve function during the oxidation of ketone bodies. This apparent lack of an effect by carnitine can be explained by the possibility that the exogenous carnitine does not have a significant effect on the intramitochondrial pool of CoASH. This notion is supported by the work of Brass and Hoppel, who demonstrated that the exchange between acylcarnitine and acyl-CoA pools is low in the liver (22) and that elevated levels of extramitochondrial carnitine do not affect intramitochondrial metabolism (21) . It is therefore possible that there is insufficient equilibration of the exogenous carnitine with the mitochondrial pool of carnitine. While it is also possible that the addition of carnitine inhibited citric acid cycle flux by limiting the availability of acetyl-CoA to the citric acid cycle, this medianism is unlikely because the tissue content ofacetyl-CoA in hearts perfused with acetoacetate and carnitine was similar to that in hearts that oxidized glucose and exhibited better function (data not presented).
In contrast to the findings with the addition of carnitine to hearts oxidizing acetoacetate, the supplementation ofthe available CoASH through the provision ofCoA precursors resulted in an improvement in performance. Because it is the intramitochondrial pool ofCoASH that is critical to 2-oxoglutarate dehydrogenase flux, the provision ofCoA precursors must necessarily enrich this pool. In the present case, there is evidence to suggest that the provision of greater amounts of CoASH improves 2-oxoglutarate flux in the form of a decreased tissue content of 2-oxoglutarate and an increased tissue content of succinyl-CoA. While the initial steps ofCoA synthesis occur in the cytosol, the conversion of 4'-phosphopantetheine to dephosphocoenzyme A and finally to CoA can occur in both the cytosol and mitochondria (29-31). Therefore, the addition of exogenous precursors ofCoA can affect the intramitochondrial pool of CoA.
It is interesting to note that the CoA content ofthe rat heart is decreased by insulin (32) but increased by either acute streptozotocin diabetes or fasting (33). These changes in CoA are to be expected because of the greater dependence on fatty acids and ketone bodies in diabetes and fasting. However, it has also been shown that the phosphorylation of pantothenic acid to 4'-phosphopantothenic acid, the rate-limiting step of CoA synthesis, is depressed in diabetic hearts (34) and inhibited by the ketone body ,B-hydroxybutyrate (35) . Further investigation is necessary to determine the effects of diabetes on ketone bodymediated failure in the heart. Specifically, is the diabetic heart more resistant to ketone body-mediated failure by virtue ofan increased content of CoA, or does the inhibition of pantothenate kinase (both by the diabetic state and by the provision of ketone bodies as a significant energy substrate) accelerate the inhibition of citric acid cycle flux and contractile failure?
In summary, the metabolism of ketone bodies in rat heart results in inhibition of citric acid cycle flux at the level of 2-oxoglutarate dehydrogenase through limitation ofthe intramitochondrial supply ofthe required cofactor CoASH. This limitation results from the sequestration of CoASH as the thioesters acetoacetyl-CoA and acetyl-CoA. While the addition of L-carnitine does not improve function for hearts oxidizing acetoacetate, it is possible that there is not an adequate equilibration ofthe exogenous pool ofcarnitine with the intramitochondrial carnitine, such that not enough CoASH was made available to enter into the 2-oxoglutarate dehydrogenase reaction. However, enrichment ofthe supply of CoA and CoASH in the heart both reverses the inhibition of2-oxoglutarate dehydrogenase and improves contractile performance during the oxidation of ketone bodies. These findings underscore the fact that the supply ofCoASH is central to ketone body metabolism and proper citric acid cycle functioning. Because ketone bodies represent a significant energy source for the heart, especially during fasting and diabetic ketoacidosis, it is important to under--stand the regulation of ketone body metabolism as well as the effects of ketone body oxidation on citric acid cycle functioning and, ultimately, the functioning of the heart.
